| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,701 | 3,215 | 5,370 | 4,173 | | Cost of Revenue | 1,298 | 1,437 | 1,745 | 1,577 | | | Gross Profit | 2,403 | 1,778 | 3,625 | 2,596 | | | Operating Expenses | | Research Development | 749 | 1,043 | 1,107 | 994 | | Selling General and Administrative | 2,651 | 3,004 | 2,862 | 2,879 | | Non Recurring | 25 | 829 |
-
| 50 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,022) | (3,098) | (344) | (1,327) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| (2,089) |
-
| | Earnings Before Interest And Taxes | (1,193) | (3,098) | (2,433) | (1,327) | | Interest Expense | (121) | 121 | (989) | 391 | | Income Before Tax | (1,072) | (3,219) | (1,444) | (1,718) | | Income Tax Expense |
-
| (179) | 75 | 45 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,072) | (3,040) | (1,519) | (1,763) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,072) | (3,040) | (1,519) | (1,763) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,072) | ($3,040) | ($1,519) | ($1,763) |
|
0.11% Nasdaq 0.00%
Income Statement
